Clinical trial
A Phase III Multicentre Trial of Weekly Induction Chemotherapy Followed by Standard Chemoradiation Versus Standard Chemoradiation Alone in Patients With Locally Advanced Cervical Cancer
NCT01566240 is registered in ClinicalTrials.gov with University College, London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Multicentre Trial of Weekly Induction Chemotherapy Followed by Standard Chemoradiation Versus Standard Chemoradiation Alone in Patients With Locally Advanced Cervical Cancer
- Lead sponsor
- University College, London
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- November 8, 2012
- Completion date
- December 31, 2026
- Enrollment
- 500 (actual)
- Sites
- 35
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer